YCANTH Trademark

Trademark Overview

On Tuesday, July 30, 2019, a trademark application was filed for YCANTH with the United States Patent and Trademark Office. The USPTO has given the YCANTH trademark a serial number of 88550445. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 6, 2023. This trademark is owned by Verrica Pharmaceuticals Inc.. The YCANTH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products and preparations for the treatment of dermatological diseases
ycanth

General Information

Serial Number88550445
Word MarkYCANTH
Filing DateTuesday, July 30, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 6, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 3, 2019

Trademark Statements

Goods and ServicesPharmaceutical products and preparations for the treatment of dermatological diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, August 11, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVerrica Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380
Party NameVerrica Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWest Chester, PA 19380

Trademark Events

Event DateEvent Description
Monday, March 6, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 6, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 8, 2022SOU EXTENSION 5 GRANTED
Wednesday, July 27, 2022SOU EXTENSION 5 FILED
Monday, August 8, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 27, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, January 25, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 21, 2022SOU EXTENSION 4 GRANTED
Friday, January 21, 2022SOU EXTENSION 4 FILED
Friday, January 21, 2022SOU TEAS EXTENSION RECEIVED
Saturday, June 19, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2021SOU EXTENSION 3 GRANTED
Thursday, June 17, 2021SOU EXTENSION 3 FILED
Thursday, June 17, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 26, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 22, 2021SOU EXTENSION 2 GRANTED
Friday, January 22, 2021SOU EXTENSION 2 FILED
Friday, January 22, 2021SOU TEAS EXTENSION RECEIVED
Saturday, July 25, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 23, 2020SOU EXTENSION 1 GRANTED
Thursday, July 23, 2020SOU EXTENSION 1 FILED
Thursday, July 23, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, January 28, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 3, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 3, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 13, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, October 30, 2019ASSIGNED TO LIE
Friday, October 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 25, 2019EXAMINER'S AMENDMENT ENTERED
Friday, October 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, October 25, 2019EXAMINERS AMENDMENT E-MAILED
Friday, October 25, 2019EXAMINERS AMENDMENT -WRITTEN
Thursday, October 24, 2019ASSIGNED TO EXAMINER
Sunday, August 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 2, 2019NEW APPLICATION ENTERED

Related Keywords

ycanth dermatological diseases treatment preparations products pharmaceutical